Evaluating Hospital Resource Utilization for Hypoplastic Left Heart Syndrome Through Linkage of a Clinical Registry

Katherine E Bates1, Li Huang2, Colleen Mangeot3

  • 1Division of Pediatric Cardiology, Congenital Heart Center, C.S. Mott Children'S Hospital, University of Michigan Medical School, 1540 E. Hospital Drive, Ann Arbor, MI, 48109-4204, USA. kebates@med.umich.edu.

Pediatric Cardiology
|March 11, 2025
PubMed

Insights

Estimating healthcare costs for hypoplastic left heart syndrome (HLHS) is crucial. Resource utilization for HLHS patients is highest in the first year of life, with significant costs and hospital days persisting through age six.

Area of Science:

  • Pediatric Cardiology
  • Health Services Research
  • Congenital Heart Disease

Background:

  • Resource utilization for hypoplastic left heart syndrome (HLHS) in early childhood is not well-established.
  • HLHS requires complex, multi-stage surgical interventions and lifelong specialized care.

Purpose of the Study:

  • To estimate hospital resource utilization, including costs and length of stay, for a contemporary cohort of HLHS patients from birth through the first six years of life.
  • To assess the feasibility of linking clinical registry data with administrative databases for resource utilization studies.

Main Methods:

  • Linked the National Pediatric Cardiology Quality Improvement (NPC-QIC) clinical registry with the Pediatric Health Information Systems (PHIS) database.
  • Included patients discharged from their Norwood procedure between October 1, 2009, and September 30, 2015.
  • Calculated estimated costs and length of stay for all inpatient episodes across the first six years of life.

Main Results:

  • Linked 973 patients (82.8%) from 33 centers; complete cost data were available for 38%.
  • Resource use was highest in the first year of life: average cost of $450,124 and 79 hospital days.
  • Total average cost in the first six years was $651,006 with 110 hospital days. Norwood, Stage 2, and Fontan procedures averaged $239,936, $143,292, and $77,198 respectively.

Conclusions:

  • Linking NPC-QIC and PHIS data is a feasible method for evaluating resource utilization in HLHS.
  • Hospital resource utilization for HLHS is substantial, particularly in the first year of life, and remains high throughout early childhood.
  • Findings highlight the significant economic burden of HLHS and inform healthcare resource planning.

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810